Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 17, Iss. 3, 2018-02 ,pp. : 161-166

Bentham Science Publishers

Access to resources Recommend Favorite

JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

The implication of identifying JAK2 V617F in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis

By Olsen Randall  

Journal of Hematopathology, Vol. 1, Iss. 2, 2008-09 ,pp. : 111-117

Springer Publishing Company

Access to resources Recommend Favorite

Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 6, 2015-12 ,pp. : 766-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms

By Fantasia Francesca   Capua Emma   Cenfra Natalia   Pessina Gloria   Mecarocci Sergio   Rago Angela   Cotroneo Ettore   Busanello Anna   Equitani Francesco   Lo-Coco Francesco   Nervi Clara   Cimino Giuseppe  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 609-616

Springer Publishing Company

Access to resources Recommend Favorite